TNFA (TNF Pharmaceuticals, Inc.) Short-Term Debt to Capital

TNF Pharmaceuticals (TNFA) focuses on developing oral TNF inhibitors, advancing the drug MYMD-1 to combat age-related decline and autoimmune dysfunction. The business is currently revising its R&D plans, adapting anti-inflammatory developments to meet the needs of gerontology. Despite fierce patent battles, the company relies on a unique method of protein targeting. This chart shows the market price is fixed at 0.00.

Ratio of Short-Term Indebtedness to Capital: tnfpharma.com (TNFA) for 07/25/2024 - 09/25/2025

Analytical breakdowns for TNF Pharmaceuticals

- stock quotes and analyst forecast:
Stock Price TNF Pharmaceuticals|TNFA - Fair Value Consensus
- business market valuation indicators:
Market Capitalization TNF Pharmaceuticals Inc.|TNFA - Enterprise Value
- book capitalization information:
Net Assets per Single Share TNF Pharmaceuticals|TNFA - Accounting Value of Company|Market Value to Book Value Ratio tnfpharma.com|TNFA - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital TNF Pharmaceuticals|TNFA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio TNF Pharmaceuticals|TNFA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio TNF Pharmaceuticals Inc.|TNFA - Long-Term Debt|Company Current Liabilities TNF Pharmaceuticals|Quick Ratio tnfpharma.com
- company profitability and valuation multiples indicators:
TNFA - Final Profit
Fundamental valuation:TNFA TNF Pharmaceuticals, Inc.

To protect capital amid volatility, it is crucial for investors to monitor the ratio of liabilities maturing within one year to equity, which allows for an assessment of current liquidity and credit risk; analyzing changes in short-term debt relative to equity helps determine the extent to which TNF Pharmaceuticals (TNFA) strategic alliances with biotech laboratories are funded via short-term loans, thereby impacting the company's investment attractiveness.

Competitors of TNF Pharmaceuticals (TNFA)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|BioHarvest Sciences Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio EXOZ (Invizyne Technologies)|ORMP - Short-Term Debt to Equity|ENTX (Entera Bio Ltd.) - Short-Term Debt to Capital Ratio|HYFT: Short-Term Debt to Capital|Current Liabilities to Equity ABVC (abvcpharma.com)|Short-Term Debt to Equity Ratio CPIX|QNTM: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity FibroGen Corp (FGEN)|TELO: Current Liabilities to Equity|Short-Term Debt to Capital RANI (Rani Therapeutics Holdings, Inc.)|Ratio of Short-Term Indebtedness to Capital SNYR|Rallybio Corp. - Short-Term Debt to Capital|LEXX - Short-Term Debt to Capital|Pulmatrix Corp (PULM) - Short-Term Debt to Equity|Pheton Holdings - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aptorum Group Ltd|Short-Term Debt to Equity Ratio lyratherapeutics.com (LYRA)|Short-Term Debt to Capital IBO|Short-Term Debt to Capital cbdmd.com (YCBD)|Short-Term Debt to Capital PRFX (PainReform Limited)|CYTO - Short-Term Debt to Equity Ratio|Lipella Pharmaceuticals - Short-Term Debt to Capital|Current Liabilities to Capital optinose.com|PIRS (Pieris Pharmaceuticals, Inc.) - Short-Term Debt to Equity Ratio|Procaps Group (PROC) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PTPI|QLI (Qilian International Corp) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital SLRN|Short-Term Debt to Capital Coefficient tffpharma.com